Leadership Overview
ProPath has 4 executives leading key functions including strategic oversight, organizational development, market expansion, and operational management.
Committed to excellence in diagnostic precision, ProPath delivers comprehensive subspecialty pathology services to healthcare providers nationwide while maintaining a physician-owned model that prioritizes patient outcomes and clinical accuracy.
Committed to excellence in diagnostic precision, ProPath delivers comprehensive subspecialty pathology services to healthcare providers nationwide while maintaining a physician-owned model that prioritizes patient outcomes and clinical accuracy.
Leadership Roles at ProPath
David Baquerizo - Chief Executive Officer
David Baquerizo, the Chief Executive Officer at ProPath, directs the overarching strategic vision for this physician-owned pathology practice. Baquerizo manages the integration of subspecialty diagnostic services across the national network, ensuring clinical excellence remains the primary focus. By aligning corporate objectives with the needs of healthcare providers, the Chief Executive Officer drives sustainable growth and operational efficiency. David Baquerizo monitors the performance of diagnostic laboratories to maintain high standards of accuracy and turnaround times. This leadership role involves constant collaboration with the board to refine the long-term business model. Through the implementation of advanced diagnostic technologies, the Chief Executive Officer optimizes service delivery for patients across the United States. Baquerizo secures the financial health of the organization while fostering a culture of medical innovation. Ultimately, the Chief Executive Officer maintains the reputation of the practice as a leader in the pathology sector.
Daniel Maganjo - Co-Founder & Chief Executive Officer
Daniel Maganjo, the Co-Founder & Chief Executive Officer at ProPath, architects the foundational growth strategies and long-term institutional goals for the practice. Maganjo oversees the expansion of subspecialty pathology capabilities, ensuring the organization adapts to evolving diagnostic requirements in the healthcare market. As the Co-Founder & Chief Executive Officer, Maganjo coordinates with clinical leadership to maintain the physician-owned integrity of the firm. This role involves identifying new opportunities for regional market penetration and enhancing the service portfolio. Daniel Maganjo evaluates the impact of diagnostic advancements on patient care, driving the adoption of cutting-edge methodologies. By managing high-level partnerships with hospital systems, the Co-Founder & Chief Executive Officer strengthens the national footprint of the company. Maganjo ensures that the core mission of providing precise, timely pathology results remains central to every operational decision. The Co-Founder & Chief Executive Officer sustains the competitive advantage of the practice through rigorous quality control.
Pat Jenevein - President
Pat Jenevein, the President at ProPath, executes the daily operational strategies that support the delivery of subspecialty pathology services. Jenevein manages the internal workflows and resource allocation necessary to maintain high-volume diagnostic throughput. As the President, Jenevein ensures that laboratory operations meet the stringent requirements of healthcare partners across the country. This leadership role involves streamlining administrative processes to improve overall efficiency and service reliability. Pat Jenevein collaborates with the executive team to implement policies that enhance the physician-owned practice model. By overseeing the operational infrastructure, the President supports the clinical staff in providing accurate and timely results. Jenevein monitors key performance indicators to identify areas for process improvement and cost management. The President drives the execution of organizational goals, ensuring that the company maintains its status as a premier diagnostic provider. Jenevein secures the operational stability of the firm through diligent management of resources and personnel.
Rinah Lidonde - Chief Marketing Officer
Rinah Lidonde, the Chief Marketing Officer at ProPath, directs all brand positioning and outreach initiatives for the nationwide pathology practice. Lidonde manages the communication strategy to ensure healthcare providers understand the value of subspecialty diagnostic services. Overseeing the development of marketing collateral, the Chief Marketing Officer highlights the clinical expertise of the physician-owned team. This leadership role involves analyzing market trends to identify growth opportunities in various regional sectors. Rinah Lidonde coordinates with the sales and operations teams to align promotional efforts with service capacity. By executing targeted campaigns, the Chief Marketing Officer increases awareness of the diagnostic capabilities offered by the firm. Lidonde monitors the effectiveness of outreach programs to optimize engagement with medical facilities. The Chief Marketing Officer drives the expansion of the brand presence, ensuring the practice remains the preferred partner for pathology services. Lidonde secures the market position of the company through consistent and professional messaging.
Explore Leadership Teams in Healthcare Services
Inland Imaging has had the opportunity to provide Radiology Services in the Northwest since 1998. At Inland Imaging everything we do is guided by our Core Purpose and Values. It's our mission and our commitment to live our purpose and values every day and in every interaction with our patients, our providers, and with each other. The organization's nearly 100 subspecialty radiologists work with health care providers, hospitals, and clinics in Western, Central and Eastern Washington, Northern Idaho, and Western Montana to deliver fast, accurate diagnostic imaging and answers that help guide and support patient care. Inland also operates and manages multiple conveniently located outpatient imaging centers equipped with state-of-the-art technology.
Company Leadership SR

JH

OPKO Health, Inc. is a fully integrated, diversified healthcare company founded in 2006 and headquartered in Miami, Florida. The company operates across two primary segments Pharmaceuticals and Diagnostics engaged in the discovery, development, and commercialization of medicines and diagnostic testing services for serious diseases. Its diagnostics operations include a large clinical reference laboratory offering a broad range of testing services spanning molecular diagnostics, genetics, anatomical pathology, and women's health. Its pharmaceutical operations focus on developing and commercializing treatments across endocrinology and other therapeutic areas, as well as advancing multispecific antibody therapies for oncology and infectious disease through its biotechnology subsidiary. OPKO Health operates across the United States and internationally, with established pharmaceutical platforms in multiple countries. The company trades on the NASDAQ under the ticker symbol OPK.
Company Leadership

AA

NSW Health Pathology is Australia's largest public pathology and forensic science service, operating over 60 laboratories and 150 collection centers across New South Wales. The organization is dedicated to enhancing health, safety, and wellbeing at all life stages, providing a wide range of clinical and forensic pathology services. It serves patients, healthcare professionals, and researchers, accepting all referrals and offering bulk billing for Medicare-rebatable tests. With a commitment to innovative research and community support, NSW Health Pathology employs more than 5,000 staff and plays a crucial role in public health.
Company Leadership TM

JP
DC
RAYUS Radiology, formerly Center for Diagnostic Imaging, is one of the nation's leading providers of high-quality diagnostic imaging and interventional radiology services through its network of imaging centers, ambulatory surgery centers, and mobile imaging solutions.
Company Leadership JO
KC

EE